A new perspective in Pediatric Research is drawing attention to a problem that often hides in plain sight: medicine cannot reliably diagnose, compare, or treat conditions unless clinicians agree on what those conditions actually mean. In “What’s in a name? The critical importance of definitions in clinical medicine,” Molloy, Schuh, Corsini and colleagues examine why clinical terminology is far more than professional shorthand. A diagnosis is also a framework for research, a trigger for treatment, a basis for public-health reporting, and a label that can shape a patient’s entire medical journey.
In everyday clinical practice, words such as “sepsis,” “prematurity,” “respiratory failure,” or “long-term condition” may appear precise while carrying different meanings in different hospitals, specialties, or studies. One clinician may define a condition by symptoms, another by laboratory values, and a third by the treatment a patient receives. These definitions can overlap without being identical. The result is a form of diagnostic instability: two patients with similar biology may receive different labels, while two patients carrying the same label may have substantially different diseases.
The technical issue is not simply vocabulary. Clinical definitions determine which observations count as evidence and where the boundaries of a disease are drawn. A definition may specify thresholds for oxygen levels, blood pressure, inflammatory markers, imaging findings, or the duration of symptoms. Changing even one threshold can alter who is classified as sick, who qualifies for a clinical trial, and how frequently the condition appears in hospital statistics. In that sense, definitions function like filters applied to medical reality: they make certain patterns visible while excluding others.
This matters especially in pediatrics, where normal physiology changes rapidly with age, body size, gestational maturity, and developmental stage. A heart rate or respiratory rate considered abnormal in an adult may be expected in an infant. A laboratory value may have different implications in a newborn than in an adolescent. Definitions that fail to account for these differences can misclassify children, complicate comparisons between age groups, and obscure meaningful changes in health. A label that appears universal may therefore conceal a set of age-dependent assumptions.
The consequences extend directly into medical research. Investigators rely on case definitions to assemble study populations and measure outcomes. If one trial defines a complication using clinical symptoms while another requires imaging confirmation, their results may not be comparable even when they use the same disease name. This affects systematic reviews, meta-analyses, and clinical guidelines, because researchers may unknowingly combine populations that were never defined in the same way. Apparent disagreements between studies can sometimes reflect differences in terminology rather than differences in biology or treatment effectiveness.
Definitions also influence the design of clinical trials. Eligibility criteria decide who is included, while outcome definitions determine whether an intervention is judged successful. A treatment may seem beneficial when “improvement” means a reduction in symptoms, but less effective when improvement requires a measurable change in organ function. Conversely, a highly restrictive definition may produce a scientifically uniform study population that does not resemble the diverse patients encountered in routine care. The choice between precision and real-world applicability is therefore not merely statistical; it is a central scientific decision.
The authors’ focus has particular relevance in an era of electronic health records, large databases, and artificial intelligence. Digital systems often treat diagnostic labels as standardized data, yet the same code can represent different clinical judgments across institutions. Algorithms trained on inconsistent labels may learn patterns associated with documentation habits, access to testing, or local treatment policies instead of the underlying disease. Clear definitions, transparent criteria, and careful validation are essential if computational tools are to support diagnosis rather than reproduce hidden inconsistencies.
For patients and families, the stakes are equally significant. A clinical label can influence access to specialist care, eligibility for support services, insurance decisions, and how future clinicians interpret a medical history. Ambiguous terminology can create confusion, while changing definitions may make patients feel that their diagnosis has been withdrawn or reclassified. The challenge is not to eliminate all uncertainty—biology is often continuous rather than neatly divided into categories—but to communicate what a label includes, what it excludes, and how confident clinicians are in applying it.
The message emerging from this work is timely: before asking whether a disease is increasing, whether a treatment works, or whether two studies agree, medicine must ask what exactly is being counted. Strong clinical definitions should be clinically meaningful, measurable, reproducible, transparent about uncertainty, and adaptable to differences in age and context. Establishing that common language may not generate the same headlines as a new drug or diagnostic device, but it can determine whether those innovations are evaluated fairly. In modern medicine, a name is never just a name; it is the starting point for evidence.
Subject of Research: Definitions in clinical medicine, with particular relevance to pediatric clinical practice and medical research.
Article Title: What’s in a name? The critical importance of definitions in clinical medicine
Article References: Molloy, E.J., Schuh, M.P., Corsini, I. et al. What’s in a name? The critical importance of definitions in clinical medicine. Pediatr Res (2026). https://doi.org/10.1038/s41390-026-05332-6
Image Credits: AI Generated
